APOA1 and cardiovascular disorder: However, given that total apoA-I plasma concentrations in A164S carriers are equivalent to noncarriers, increased A164S catabolism due to impaired short-term lipid binding is unlikely to explain the disparity in cardiovascular disease and mortality between these populations.